FDA Inspection 1270105 — Boston University National Emerging Infectious Disease Laboratories
The FDA completed an inspection of Boston University National Emerging Infectious Disease Laboratories on May 16, 2025 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 16, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
Animal Rule-Specific Study